International Drug Development Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014110
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and eClinical services comprise protocol design, central randomization, clinical data management, electronic data capture, biostatistics and medical writing. IDDI’s risk-based monitoring services include risk indicator and central statistical monitoring. The institute provides clinical research services in therapeutics areas such as oncology, ophthalmology, cardiology and biosimilars. It caters to pharmaceutical companies, biotechs, start-ups, academic groups and CROs. IDDI is headquartered in Louvain-la-Neuve, Belgium.

International Drug Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
International Drug Development Institute Partners with Ophthotech 9
International Drug Development Institute Partners with Oraya Therapeutics 10
International Drug Development Institute Partners with Exonhit 11
International Drug Development Institute Partners with Medsource 12
International Drug Development Institute Partners with Sanofi Pasteur 13
International Drug Development Institute Partners with Pharmasset 14
International Drug Development Institute Partners with Helsinn 15
International Drug Development Institute – Key Competitors 16
International Drug Development Institute – Key Employees 17
International Drug Development Institute – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International Drug Development Institute, Pharmaceuticals & Healthcare, Key Facts 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
International Drug Development Institute Partners with Ophthotech 9
International Drug Development Institute Partners with Oraya Therapeutics 10
International Drug Development Institute Partners with Exonhit 11
International Drug Development Institute Partners with Medsource 12
International Drug Development Institute Partners with Sanofi Pasteur 13
International Drug Development Institute Partners with Pharmasset 14
International Drug Development Institute Partners with Helsinn 15
International Drug Development Institute, Key Competitors 16
International Drug Development Institute, Key Employees 17
International Drug Development Institute, Subsidiaries 18

★海外企業調査レポート[International Drug Development Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • StarTek Inc (SRT):企業の財務・戦略的SWOT分析
    Summary StarTek Inc (StarTek) is a business process outsourcing company that offers contact center and customer engagement solutions. The company offers service solutions, technology solutions and customer experience suppor. Its service solution provides multi-channel customer interactions across vo …
  • Skechers U.S.A., Inc. (SKX):企業の財務・戦略的SWOT分析
    Skechers U.S.A., Inc. (SKX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Vossloh AG:企業のM&A・事業提携・投資動向
    Vossloh AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vossloh AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Speedway Motorsports Inc (TRK):企業の財務・戦略的SWOT分析
    Summary Speedway Motorsports Inc (SMI) is a marketer, promoter and sponsor of motorsports entertainment. The company offers smaller-scale, modified racing cars and parts. It also produces and broadcasts syndicated motorsports programming to radio stations. SMI offers souvenir merchandising including …
  • NTT DOCOMO, Inc.:企業のM&A・事業提携・投資動向
    NTT DOCOMO, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT DOCOMO, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報
    Summary Grindeks focuses on the research, development, manufacture and marketing of novel pharmaceuticals, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in cardiovascular, central nervous system (CNS) and cancer therapeutic categories …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Century Enka Limited:企業の戦略・SWOT・財務分析
    Century Enka Limited - Strategy, SWOT and Corporate Finance Report Summary Century Enka Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Blue Star Ltd (BLUESTARCO):企業の財務・戦略的SWOT分析
    Summary Blue Star Ltd (BSL) is an air conditioning and commercial refrigeration company that manufactures cooling products. The company’s products include room air conditioners, air purifiers, water purifiers, air coolers, water coolers, cold storages and specialty products. It also offers deep free …
  • Astaldi Spa
    Astaldi Spa - Strategy, SWOT and Corporate Finance Report Summary Astaldi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • VeriFone Systems Inc:企業の戦略・SWOT・財務情報
    VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report Summary VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Omega Pharma NV:企業のM&A・事業提携・投資動向
    Omega Pharma NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Omega Pharma NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆